Inhibitors of DPP-4, such as sitagliptin, vildagliptin and linagliptin, inhibit DPP-4, resulting in an increase of incretin and GLP-1 secretion (Figure 1), leading to an improvement in plasma glucose control without inducing hypoglycemia or increasing the body weight.69 Both types of drugs are barely metabolized in the liver and are excreted unchanged by the kidney;70 thus, they seem to be safe in cirrhotic patients.71 Unlike the old antidiabetic drugs, their pharmacodynamic characteristics have been assessed in patients with varying degrees of hepatic impairment and their safety has been assessed in studies comprising large number of individuals
Management of diabetes mellitus
Research on LLLT suggests red and near-infrared light therapy may help calm inflammation, support circulation, and stimulate mitochondria in wrist tissues, particularly when combined with splints, ergonomic adjustments, or physical therapy
doi:10.15420/cfr.2020.19 GLP1RAs in Clinical Practice: Therapeutic Advances and Safety Perspectives
~ AlphaMD If you've landed on this article, there's a good chance you're frustrated
I have noticed inches reduced in my midsection and workout stamina has improved